Le Lézard
Classified in: Science and technology, Business
Subjects: CHI, FNC

Westbrooke completes investment in UK nursery schools buy-and-build platform


LONDON, Nov. 13, 2023 /PRNewswire/ -- Westbrooke Alternative Asset Management UK ("Westbrooke") is pleased to announce the successful conclusion of a preferred equity investment in Toots Day Nursery Investments Ltd ("Toots"), a platform for a "buy-and-build" in the UK Children's Nurseries sector, in partnership with Tracey Storey and Ed David. This is Westbrooke's second transaction backing this team, who successfully executed and exited a similar strategy at ICP Nurseries.

James Stirling, Head of Westbrooke's Hybrid Capital strategy in the UK commented, "We are thrilled to be working with Ed & Tracey again to support their latest buy-and-build strategy. They have a strong, values-led approach to education provision, focused on raising aspirations and inspiring positive change in learners, and they have a proven, first-class track record of value creation in the sector."

This investment fits squarely within Westbrooke's ambition to back excellent management teams to help them deliver their growth ambitions within UK lower-mid-market companies, with highly flexible funding solutions.

Tracey Storey, Chair at Toots said, "We are really pleased to be working with Westbrooke again as we look to build a group of high-quality nursery schools across the country. Having worked with Westbrooke previously, we really value their pragmatic and commercial approach, and know they will be a highly supportive partner for what will be an exciting journey ahead."

Westbrooke UK (FRN 792259) is an appointed representative of Capricorn Capital Partners UK Limited (FRN748414) which is authorised and regulated by the Financial Conduct Authority.

Click here for the full disclaimer.

For further information on the funding solutions we offer, please get in touch with James Stirling at [email protected] or Kieran McKenzie at [email protected]. Telephone +44 203 597 0153

 


These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

18 mai 2024
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...



News published on and distributed by: